These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 16273098

  • 1. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
    Wei SH, Rosen H, Matheu MP, Sanna MG, Wang SK, Jo E, Wong CH, Parker I, Cahalan MD.
    Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
    [Abstract] [Full Text] [Related]

  • 2. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y, Seki N, Sato N, Sugahara K, Chiba K.
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [Abstract] [Full Text] [Related]

  • 3. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
    Alfonso C, McHeyzer-Williams MG, Rosen H.
    Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
    [Abstract] [Full Text] [Related]

  • 4. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
    Gollmann G, Neuwirt H, Tripp CH, Mueller H, Konwalinka G, Heufler C, Romani N, Tiefenthaler M.
    Int Immunol; 2008 Jul; 20(7):911-23. PubMed ID: 18495625
    [Abstract] [Full Text] [Related]

  • 5. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
    Sensken SC, Nagarajan M, Bode C, Gräler MH.
    J Immunol; 2011 Mar 15; 186(6):3432-40. PubMed ID: 21289303
    [Abstract] [Full Text] [Related]

  • 6. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H, Zimmermann K, Kleuser B.
    Arch Immunol Ther Exp (Warsz); 2006 Mar 15; 54(4):239-51. PubMed ID: 16830220
    [Abstract] [Full Text] [Related]

  • 7. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A, Pfeilschifter J.
    Biochem Pharmacol; 2008 May 15; 75(10):1893-900. PubMed ID: 18321471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V, Chwalla I, Siess W.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):603-8. PubMed ID: 18402775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Off the shelf but not mass produced.
    Karliner JS.
    Chem Biol; 2005 Jun 13; 12(6):614-5. PubMed ID: 15975506
    [Abstract] [Full Text] [Related]

  • 12. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H, Maeda Y, Yano K, Sugahara K, Chiba K, Kohno T, Igarashi Y.
    Cell Mol Immunol; 2006 Dec 13; 3(6):429-37. PubMed ID: 17257496
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H.
    Science; 2002 Apr 12; 296(5566):346-9. PubMed ID: 11923495
    [Abstract] [Full Text] [Related]

  • 15. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S, Bergelin N, Löf C, Vainio M, Andersson S, Törnquist K.
    Endocr Relat Cancer; 2008 Jun 12; 15(2):521-34. PubMed ID: 18509004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C, Spyridopoulos I, Chun J, Brinkmann V, Keul P, Levkau B, Zeiher AM, Dimmeler S, Haendeler J.
    Arterioscler Thromb Vasc Biol; 2007 Feb 12; 27(2):275-82. PubMed ID: 17158356
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
    Sanna MG, Wang SK, Gonzalez-Cabrera PJ, Don A, Marsolais D, Matheu MP, Wei SH, Parker I, Jo E, Cheng WC, Cahalan MD, Wong CH, Rosen H.
    Nat Chem Biol; 2006 Aug 12; 2(8):434-41. PubMed ID: 16829954
    [Abstract] [Full Text] [Related]

  • 19. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, Bruns CJ, Jauch KW, Heeschen C, Graeb C.
    J Cell Biochem; 2007 May 01; 101(1):259-70. PubMed ID: 17203465
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG.
    Nature; 2004 Jan 22; 427(6972):355-60. PubMed ID: 14737169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.